Iopromide clinical trials
Also written Ultravist®.
How each study uses iopromide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 10 May 1995 · ULTRAVIST 150 · NDA 020220 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2005 (1)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 2
Bayer (1) · Chinese PLA General Hospital (1) · Ospedale San Donato (1) · GE Healthcare (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses iopromide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Pediatric Risk of Hypothyroidism With Iodinated Contrast MediaWithdrawnPhase 4GE HealthcareNCT03631771Written as IopromideHow we know
- Ultravist: Safety and Efficacy in Computed Tomography of Head and BodyCompletedPhase 3BayerNCT00244140Written as Iopromide 370 mg I/mLHow we know
- A Safety Comparison of Iopromide and Iodixanol in Renal Impaired PatientsCompletedPhase 4Chinese PLA General HospitalNCT00926562Written as Iopromide (Ultravist)How we know
- Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)CompletedPhase 4Ospedale San DonatoNCT00827788Written as IopromideHow we know
As the comparator · 2 — what is tested is compared with iopromide
Codes
What other systems call iopromide · ClinicalTrials.gg INT003089
- MeSH (NLM) C038192iopromideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 712BAC33MZIOPROMIDEConfirmed FDA, NLM, Wikidata
- RxNorm 27781Confirmed FDA, Wikidata
- Wikidata Q4202805iopromideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1137IopromideOne source FDA
- DrugBank DB09156One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C038192 | iopromide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 712BAC33MZ | IOPROMIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 27781 | — | Confirmed FDA, Wikidata |
| Wikidata | Q4202805 | iopromide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1137 | Iopromide | One source FDA |
| DrugBank | DB09156 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.